Key result
Extra-cardiac vascular disease linked to ~73% higher in-hospital mortality in ACS undergoing PCI.
Why the study?
The impact of extra-cardiac vascular diseases on outcomes of ACS patients in the era of transradial coronary intervention was unclear.
Does the presence of extra-cardiac vascular disease increase the risk of mortality and bleeding complications in ACS patients undergoing PCI?
Cohort (n=7,980)
Yes
Does the presence of extra-cardiac vascular disease increase the risk of mortality and bleeding complications in ACS patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
Concurrent extra-cardiac vascular disease in ACS patients undergoing PCI is associated with increased mortality and bleeding, although bleeding risks have declined recently alongside the increased adoption of transradial interventions.
BACKGROUND: Extra-cardiac vascular diseases (ECVDs), such as cerebrovascular disease (CVD) or peripheral arterial disease (PAD), are frequently observed among patients with acute coronary syndrome (ACS). However, it is not clear how these conditions affect patient outcomes in the era of transradial coronary intervention (TRI). METHODS AND RESULTS: Among 7,980 patients with ACS whose data were extracted from the multicenter Japanese percutaneous coronary intervention (PCI) registry between August 2008 and March 2017, 888 (11.1%) had one concurrent ECVD (either PAD [345 patients: 4.3%] or CVD [543 patients; 6.8%]), while 87 patients (1.1%) had both PAD and CVD. Overall, the presence of ECVD was associated with a higher risk of mortality (odds ratio [OR]: 1.728; 95% confidence interval [CI]: 1.183-2.524) and bleeding complications (OR: 1.430; 95% CI: 1.028-2.004). There was evidence of interaction between ECVD severity and procedural access site on bleeding complication on the additive scale (relative excess risk due to interaction: 0.669, 95% CI: -0.563-1.900) and on the multiplicative scale (OR: 2.105; 95% CI: 1.075-4.122). While the incidence of death among patients with ECVD remained constant during the study period, bleeding complications among patients with ECVD rapidly decreased from 2015 to 2017, in association with the increasing number of TRI. CONCLUSIONS: Overall, the presence of ECVD was a risk factor for adverse outcomes after PCI for ACS, both mortality and bleeding complications. In the most recent years, the incidence of bleeding complications among patients with ECVD decreased significantly coinciding with the rapid increase of TRI.
No takes yet. Share an insight, caveat, or question.
Kodaira et al. (2019) conducted a cohort in Acute coronary syndrome (n=7,980). Concurrent extra-cardiac vascular disease vs. No concurrent extra-cardiac vascular disease was evaluated on In-hospital mortality (OR 1.728, 95% CI 1.183-2.524). The presence of concurrent extra-cardiac vascular disease in patients with acute coronary syndrome undergoing percutaneous coronary intervention was associated with a higher risk of in-hospital mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: